Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

Core Viewpoint - Cannara Biotech Inc. is positioned as a leading producer in the Canadian cannabis market, emphasizing its financial performance, market share growth, and cost advantages due to its operations in Québec [3]. Company Overview - Cannara Biotech Inc. operates as a vertically integrated producer of premium-grade cannabis and derivative products, with two large facilities in Québec covering over 1,650,000 sq. ft. [1][5]. - The company has a potential annual cultivation output of 100,000 kg, leveraging low electricity costs in Québec to maintain affordable pricing for its products [5]. Upcoming Presentation - Cannara will present at the Ventum Capital Markets Canadian Cannabis Conference on March 12, 2025, from 1:40 PM to 2:00 PM EST, where the CEO and CFO will discuss the company's performance and answer investor questions [1][2]. Financial Performance - The company highlights its impressive financial performance and efficient scaling, contrasting its success with competitors who struggle with profitability [3].